Chris Naprawa, a Senior Officer, acquired 100,000 Common Shares on a direct ownership basis at a price of $2.200 through a prospectus or prospectus exempt offering on February 25th, 2019. This represents a $220,000 investment into the company's shares and an account share holdings change of 7.5%.
Khiron Life Sciences is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
Khiron Life Sciences Corp, formerly Adent Capital Corp, is a Canada-based company engaged in alternative medicine sector. The Company is an integrated medical cannabis company with its core operations in Latin America. Khiron is active in the research area in medical cannabis industry. It develops and commercializes medical cannabis products mainly in Colombia.
No Comments